Mario Levis
Impact in
- Accounting top 1%
- Corporate Finance and Governance
- Auditing, Earnings Management, Governance
- Private Equity and Venture Capital
- Finance top 1%
- Financial Markets and Investment Strategies
Papers in
- Accounting 28
- Corporate Finance and Governance 27
- Private Equity and Venture Capital 8
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Umberto Ricardi (47 shared papers)Meziane Lasfer (2 shared papers)Andrea Riccardo Filippi (18 shared papers)Seraina C. Anagnostopoulou (3 shared papers)Serena Badellino (8 shared papers)Silvio Vismara (1 shared paper)Dylan C. Thomas (2 shared papers)Alessia Guarneri (8 shared papers)
- Journals
- Radiotherapy and Oncology (10 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)Journal of Banking & Finance (3 papers)Hematological Oncology (2 papers)Lung Cancer (2 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Mario Levis
90 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 89
- Accounting 921
- Finance 780
- Strategy and Management 348
- Economics and Econometrics 379
- Radiation 106
Countries citing papers authored by Mario Levis
This map shows the geographic impact of Mario Levis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Levis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Levis more than expected).
Fields of papers citing papers by Mario Levis
This network shows the impact of papers produced by Mario Levis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Levis. The network helps show where Mario Levis may publish in the future.
Co-authors
The 25 scholars most cited alongside Mario Levis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 382 | |
| 2 | 1989 | 143 | |
| 3 | 1990 | 102 | |
| 4 | 1995 | 74 | |
| 5 | 1999 | 71 | |
| 6 | 2014 | 66 | |
| 7 | 2011 | 61 | |
| 8 | 1998 | 60 | |
| 9 | 2011 | 52 | |
| 10 | Empirical issues in raising equity capital | 1996 | 47 |
| 11 | 2008 | 46 | |
| 12 | 2013 | 42 | |
| 13 | 2013 | 39 | |
| 14 | 2015 | 35 | |
| 15 | 2001 | 34 | |
| 16 | 2021 | 31 | |
| 17 | 2019 | 30 | |
| 18 | 2018 | 27 | |
| 19 | 1995 | 27 | |
| 20 | 2020 | 24 |
About Mario Levis
Mario Levis is a scholar working on Accounting, Pulmonary and Respiratory Medicine, Finance, Pathology and Forensic Medicine and Radiation, having authored 96 papers that have together received 1.8k indexed citations. Recurring topics across this work include Corporate Finance and Governance (27 papers), Financial Markets and Investment Strategies (20 papers), Advanced Radiotherapy Techniques (16 papers), Lymphoma Diagnosis and Treatment (16 papers), Financial Reporting and Valuation Research (9 papers), Housing Market and Economics (8 papers), Private Equity and Venture Capital (8 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Accounting (921 citations), Finance (780 citations), Strategy and Management (348 citations), Economics and Econometrics (379 citations) and Radiation (106 citations). Mario Levis has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Umberto Ricardi, Meziane Lasfer, Andrea Riccardo Filippi, Seraina C. Anagnostopoulou, Serena Badellino, Silvio Vismara, Dylan C. Thomas, Alessia Guarneri, Riccardo Ragona and Cristina Mantovani. Their work appears in journals such as Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Banking & Finance, Hematological Oncology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.